NYMX - Nymox Pharmaceutical Corp
Close
0.2
-0.049 -24.500%
Share volume: 932,736
Last Updated: Thu 06 Jul 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.25
-0.05
-19.68%
Summary score
57%
Profitability
68%
Dept financing
22%
Liquidity
21%
Performance
65%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2017 - 2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
30284.34%
Return on assets
-116.77%
Return on sales
-14688.42%
Return on invested capital
242.72%
Total debt ratio
75.61%
Debt ratio change over timeo
-0.59%
Current Ratio
2.98%
Quick Ratio
2.96%
Cash Position Ratio
2.9%
Short-term ratios 2020 - 2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
5099.68%
Return on assets
-140.85%
Return on sales
0%
Return on invested capital
217.53%
Total debt ratio
96.33%
Debt ratio change over timeo
-0.57%
Current Ratio
1.62%
Quick Ratio
1.6%
Cash Position Ratio
1.49%
Last quarter ratios 2021
The data are presented for the financials results of the last quarter.
Return on equity
20325%
Return on assets
-166.94%
Return on sales
0%
Return on invested capital
331.84%
Total debt ratio
100.82%
Debt ratio change over time
-0.7%
Current Ratio
0.94%
Quick Ratio
0.91%
Cash Position Ratio
0.78%
Performance ratios (change over 4 years) 2017 - 2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
12411.1%
Return on assets
-160.66%
Return on sales
-7478.73%
Return on invested capital
10.66%
Total debt ratio
-59.3%
Debt ratio change over time
-0.59%
Current Ratio
0.37%
Quick Ratio
0.36%
Cash Position Ratio
0.33%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NYMX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 30284.34% | 0% | 0% | 24.38% |
| Return on assets | -116.77% | 0% | 0% | -10.25% |
| Return on sales | -14688.42% | 0% | 0% | -1968.14% |
| Return on invested capital | 242.72% | 0% | 0% | 64.15% |
| Profitability | 50% | 0% | 50% | 7% |
| Total debt ratio | 75.61% | 0% | 0% | 131.68% |
| Debt ratio change over time | -0.59% | 0% | 0% | 1.11% |
| Dept financing | 14% | 0% | 0% | 50% |
| Current Ratio | 1.62% | 0% | 0% | 10.18% |
| Quick Ratio | 1.6% | 0% | 0% | 10.18% |
| Cash Position Ratio | 1.49% | 0% | 0% | 9.74% |
| Liquididy | 41% | 0% | 0% | 75% |
| Short-term ratios | NYMX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 5099.68% | 0% | 0% | -24.6% |
| Return on assets | -140.85% | 0% | 0% | -7.41% |
| Return on sales | 0% | 0% | 0% | -3259.14% |
| Return on invested capital | 217.53% | 0% | 0% | 119.23% |
| Profitability | 75% | 0% | 25% | 14% |
| Total debt ratio | 96.33% | 0% | 0% | 60.05% |
| Debt ratio change over time | -0.57% | 0% | 0% | -0.05% |
| Dept financing | 25% | 0% | 25% | 16% |
| Current Ratio | 1.62% | 0% | 0% | 10.18% |
| Quick Ratio | 1.6% | 0% | 0% | 10.18% |
| Cash Position Ratio | 1.49% | 0% | 0% | 9.74% |
| Liquididy | 12% | 0% | 0% | 75% |